Insider Transactions and Holdings
-
Entity Type
-
Company
-
Role
-
10%+ Owner
-
Issuer Symbol
-
GLUE on Nasdaq
There are no Buy or Sell transactions made by New Enterprise Associates 17, L.P. since 12 Mar 2025
Holdings reported by New Enterprise Associates 17, L.P. for Monte Rosa Therapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
7,692,298 |
$146,153,662 |
$19.00 |
28 Jun 2021 |
Direct |
|
|
| Series A-2 convertible preferred stock |
0 |
|
|
28 Jun 2021 |
Direct |
Common Stock |
|
| Series B convertible preferred stock |
0 |
|
$2.00 |
28 Jun 2021 |
Direct |
Common Stock |
|
| Series C convertible preferred Stock |
0 |
|
|
28 Jun 2021 |
Direct |
Common Stock |
|
Transactions reported by New Enterprise Associates 17, L.P. for Monte Rosa Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.